Novartis considers bypassing European government payers due to MFN
Novartis CEO Vas Narasimhan said Tuesday that launching new drugs in the private market or in a self-pay market in Europe is not off the table in response to the so-called most favored nation policy. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.